{"cluster": 65, "subcluster": 5, "abstract_phrases": [{"text": "sars-cov rbd antibodies", "rank": 0.097}, {"text": "ace2-non-blocking sars-cov rbd antibodies", "rank": 0.092}, {"text": "sars-cov-2 s protein", "rank": 0.085}, {"text": "sars-cov receptor-binding domain", "rank": 0.08}, {"text": "potent ace2-blocking sars-cov neutralizing antibodies", "rank": 0.08}], "title_phrases": [{"text": "sars-cov receptor-binding domain", "rank": 0.144}, {"text": "developmenta neutralizing human antibody", "rank": 0.139}, {"text": "recombinant receptor-binding domain", "rank": 0.126}, {"text": "receptor-binding domain", "rank": 0.124}, {"text": "binding domain", "rank": 0.115}], "title_abstract_phrases": [{"text": "sars-cov rbd antibodies", "rank": 0.101}, {"text": "ace2-non-blocking sars-cov rbd antibodies", "rank": 0.095}, {"text": "sars-cov receptor-binding domain", "rank": 0.089}, {"text": "potent ace2-blocking sars-cov neutralizing antibodies", "rank": 0.084}, {"text": "neutralizing monoclonal antibodies", "rank": 0.083}]}